NCT04000737 2025-04-13
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Yiviva Inc.
Phase 2 Completed
Clinical Trials
35 trialsNCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT06629857 2024-10-08
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Darul Sehat Hospital
Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT05823584 2024-04-10
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
TCM Biotech International Corp.
Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT01970254 2022-08-15
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
M.D. Anderson Cancer Center
Completed
NCT05406089 2022-06-21
Effects of Antiviral Therapy on Patients With HBV-related HCC
First Affiliated Hospital Xi'an Jiaotong University
Completed
NCT03528941 2022-05-12
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT04659005 2022-04-06
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Chinese University of Hong Kong
Phase NA Completed
NCT02785835 2022-03-16
GEHEP-002
Hospital Universitario de Valme
Completed
NCT00013871 2021-11-01
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
National Institute of Allergy and Infectious Diseases (NIAID)
Phase NA Completed
NCT00342186 2020-06-16
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
National Institutes of Health Clinical Center (CC)
Completed
NCT00637195 2020-01-03
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
GlaxoSmithKline
Phase 3 Completed
NCT01086709 2018-04-05
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
National Institutes of Health Clinical Center (CC)
Completed
NCT01311232 2017-10-27
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Samsung Medical Center
Completed
NCT01580202 2017-06-29
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
Seoul National University Hospital
Phase 3 Completed
NCT00888407 2017-05-30
Community-based Hepatitis B Interventions for Hmong Adults
University of California, Davis
Phase NA Completed
NCT00322361 2017-03-16
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT00760721 2016-11-28
Increasing Hepatitis B Screening Among Korean Church Attendees
University of California, Los Angeles
Phase 3 Completed
NCT00824707 2016-04-01
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT00834158 2016-04-01
TACEPVE
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT00881036 2015-09-03
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
Kyoto University Hospital
Completed
NCT02108444 2014-07-24
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Peking University
Completed
NCT02025842 2014-01-01
HBV/HCC
Azienda Ospedaliera San Camillo Forlanini
Completed
NCT01022476 2013-07-18
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT00926757 2013-05-29
HBVNHL
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed
NCT00629486 2013-04-18
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT00769730 2009-08-04
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication
Kaohsiung Medical University Chung-Ho Memorial Hospital
Completed
NCT00876148 2009-04-06
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
Azienda Ospedaliera San Giovanni Battista
Completed
NCT00222664 2005-09-22
Qidong Hepatitis B Intervention Study
University of Oxford
Phase 4 Completed